Residency Track | Explore Specialized Areas of Pharmacy Practice
Skip to main content
Residency Track

Doctor of Pharmacy (PharmD)

Residency Track 
Explore Specialized Areas of Pharmacy Practice

The Residency Track is an academic pathway specifically structured to support PCOM School of Pharmacy PharmD program students who aspire to pursue post-graduate residency training. The track offers advanced preparation through a curriculum that combines didactic instruction with hands-on experiences.

Students gain exposure to high-level clinical decision-making, patient-centered care, and evidence-based therapeutic strategies, all of which are essential for success in competitive residency programs. The track offers students the opportunity to pursue targeted electives that align with career goals and intended residency focus. These electives provide an in-depth exploration of complex clinical areas and help build competencies relevant to specialized pharmacy practice.

Upon successful completion of the track requirements, students will be recognized with a certificate of completion.

Why Choose the Residency Preparation Track

  1. Enhanced Residency Competitiveness: This academic pathway provides structured preparation for post-graduate training, equipping students with the clinical knowledge and experience that residency programs seek in applicants.
  2. Focused Clinical Training: Through specialized electives, students gain targeted expertise in high-impact areas of pharmacy practice.
  3. Credentialed Recognition: Earning a certificate of completion provides official recognition of a student’s dedication to advanced clinical training and enhances their academic and professional credentials.
  4. Career Alignment and Exploration: The track allows students to explore areas aligned with their professional interests, helping to refine career goals and prepare for specific residency focuses.
  5. Skill Development for Advanced Practice: Participation strengthens essential clinical competencies—such as critical thinking, patient care planning, and interdisciplinary collaboration—needed for success in advanced pharmacy roles.
REQUEST PROGRAM INFORMATION

Which courses will I take for the Residency Track?

The Residency Track requires the completion of four (4) credit hours of elective coursework. These courses reinforce key concepts necessary for post-graduate clinical roles and foster a deeper understanding of disease state management. Current course offerings are listed below and are subject to change. Consult the course catalog for additional information.

These courses will identify the effectiveness and potential harms of pharmacist-led chronic disease management and the referral of patients to other healthcare providers. Special emphasis is placed on specific problem solving skills involved in initiating, adjusting and discontinuing drug therapy in complex integrated cases seen in chronic disease management such as COPD, hyperlipidemia, diabetes, anticoagulation, hypertension and safe medication use in older adults.

This course will provide students with additional education about antimicrobial stewardship. The primary objective of the course is to expand and deepen student knowledge of microbiology and pharmacotherapy gained from core curriculum courses, with an emphasis on clinical application within the antimicrobial stewardship context. The course will introduce students to the principles of antimicrobial stewardship to facilitate the rationale of selection of antimicrobial regimens, stewardship interventions, quality improvement methods, and program development, implementation and evaluation.

This course is designed to focus on important knowledge involving cardiovascular pharmacotherapy. The overall objective of the course is to emphasize the need for the student to provide clinical evidence to support drug therapy recommendations in the treatment of cardiovascular diseases during their clinical clerkships and future practice. By the conclusion of this course, the student will be able to cite data from clinical trials to justify their specific drug therapy recommendations for a variety of cardiovascular diseases such as ischemic heart disease (including unstable angina, chronic stable angina, acute coronary syndrome, heart failure, atrial fibrillation, hypertension, dyslipidemia and etc.).

X